Loading...
New

In Vitro Diagnostics Market by Product & Service (Reagents, Instruments, and Software & Services), Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Others), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Others), and End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

A00245
Pages: 381
Jun 2020 | 70377 Views
 
Author(s) : Sanjivan Gill and Onkar Sumant
Tables: 156
Charts: 101
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the In Vitro Diagnostics Market

Request Now !

The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027.

In vitro diagnostics (IVD) are medical devices, which require use of assays and reagents to diagnose a medical condition. Moreover, these instruments analyze body fluids and tissue samples collected from a patient. In addition, there are various types of in vitro diagnostic instruments thatwork on different techniques such as immunodiagnostics, tissue diagnostics, hematology, and molecular diagnostics. Furthermore, in vitro diagnostics are employed in diagnosis of various medical conditions such as infectious diseases, cancer, cardiac disorders, and nephrological disorders.  Moreover, use and handling of in vitro diagnostics require technical expertise and thus, instruments are used in specialized medical facilities to carry out diagnosis. For instance, IVD products are used in facilities such as standalone laboratories, hospitals, and point-of care.

in-vitro-diagnostics-market-2020-2027-1591105414

Get more information on this report : Request Sample Pages

 

The major factor that contributes to the in vitro diagnostics market growth of the in vitro diagnostic market include surge in number of in vitro diagnostic tests, which is attributable to rise in incidences of chronic and infectious diseases. Furthermore, growth in geriatric population, which is prone to immunological disorders is another major factor that boosts the growth of the market. Moreover, rise in use of personalized medicines in treatment of various chronic diseases such as cancer also fuels the growth of the market. In addition, increase in technological advancements associated with in vitro diagnostic products, technologies, and software & services boosts the market growth. However, stringent government regulations and unfavorable reimbursement policies are anticipated to restrict the growth of the in vitro diagnostics market. On the contrary, high growth rate exhibited by developing economies present lucrative opportunities for key players in the in vitro diagnostics market during the forecast period.

Covid-19 Impact On Global In Vitro Diagnostics Market

The COVID-19 pandemic lead to nationwide lockdowns worldwide in order to observe social distancing. These lockdowns had a great impact on every business in each industry. Similarly, in vitro diagnostics market was also affected by the COVID-19 outbreak. For instance, the industry faced new challenges such as interrupted supply chains, inconsistent demand of products, and others. Furthermore, availability of raw material, and human resources was also impacted. In addition, the in vitro diagnostics industry has seen a demand for new COVID-19 test kits which is serving as a huge opportunity for the key players in IVD industry. Thus, the overall impact of COVID-19 pandemic remained positive for the key players in the in vitro diagnostics industry. However, few companies are facing a set-back due to lockdown, which has led to a drop in number of IVD tests performed across the globe. However, this deleterious impact is being compensated by the rapid demand for newly launched emergency use authorized IVD tests used for COVID-19 detection.

In Vitro Diagnostics (Ivd) Market Segmentation  

The report segments the market into product & service, technique, application, end user, and region. On the basis of product & service, the market is segmented into reagents, instruments, and services & software. On the basis of technique, it is categorized into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. In addition, the immunodiagnostics segment is further divided into enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. Moreover, the ELISAsegment is further divided into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Similarly, the molecular diagnostics segment is divided into polymerize chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarray, and others.

The clinical chemistry segment is further divided into basic metabolic panel, liver panel, lipid profile, thyroid function panel, electrolyte panel, specialty chemicals, and others.

On the basis of application, the market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. On the basis of end user, it is categorized into standalone laboratories, hospitals, academics & medical schools, point-of-care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment Review

On the basis of product & service, the reagents segment acquired major in vitro diagnostics market share of the in vitro diagnostics market. The growth of this segment is attributed to the fact that reagents are a vital part of every invitro diagnostic test. Hence, the aforementioned factors contribute to the growth of this segment. In addition, the instruments segment is expected to grow at the fastest CAGR during the forecast period, owing to rise in focus of key players toward launching of new instruments. 

In Vitro Diagnostics Market
By Product Type

Your browser does not support the canvas element.

Instruments segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

By application, the market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. The infectious diseases market has the highest potential, owing to increase in incidences of HIV-AIDS, hepatitis, and other infectious diseases.

In Vitro Diagnostics Market
By Application

Your browser does not support the canvas element.

Infectious Diseases segment held a dominant position in 2019 and will continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

North America is expected to be the leading regional market for in vitro diagnosticsduring the forecast period, owing to its well-penetrated healthcare system and higher healthcare awareness among patients, including Obama’s Affordable Care Act (ACA) act, change in technology, and rebounding American Economy. Furthermore, other factors such as easy availability of devices, rise in awareness related to use of these products, and presence of large number of geriatric populations suffering from various chronic diseases also contribute to the growth of the market. Moreover, presence of large number of key players in North America is another major factor that drives the in vitro diagnostics market growth. In addition, Asia-Pacific is expected to register fastest growth during the forecast period, owing to surge in healthcare expenditure and rise in prevalence of diabetes in the region. Other factors such as huge patient base of other chronic diseases that require IVD testing also boost the growth of market in Asia-Pacific.

In Vitro Diagnostics Market
By Geography

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 6.7% during 2020-2027.

Get more information on this report : Request Sample Pages

The global in vitro diagnostics market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum in vitro diagnostics market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current global in vitro diagnostics market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.

  • The in vitro diagnostics market forecast is studied from 2020 to 2027. 

  • The in vitro diagnostics market size and estimations are based on a comprehensive analysis of key developments in the industry.

  • A qualitative analysis based on innovative products facilitates strategic business planning.

  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key Market Segments

By Product & Service

  • Reagents
  • Instruments
  • Software and Services

By Technique

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence immunoassay (FIA)    
      • Colorimetric Immunoassay (CI)
    • Rapid Tests
    • Enzyme-Linked ImmunoSpot (ELISPOT)    
    • Radioimmunoassay (RIA)
    • Western Blot
  • Hematology
  • Molecular Diagnostics
    • Polymerize Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA diagnostics
    • Microarray
    • Others
  • Tissue Diagnostics
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Electrolyte Panel    
    • Specialty Chemicals
  • Others

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases 
  • Gastrointestinal Diseases
  • Others

By End User 

  • Standalone Laboratories
  • Hospitals
  • Academic & Medical Schools
  • Point-of-Care
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany 
    • France 
    • UK 
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China 
    • India 
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Top winning strategies, 2019
3.4.Top player positioning, 2019
3.5.Porters five forces analysis
3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Increase in incidences of chronic and infectious diseases
3.6.1.2.Technological advancements in IVD
3.6.1.3.Rise in adoption of in vitro diagnostic testing
3.6.1.4.Increase in government expenditures on healthcare
3.6.1.5.Increase in popularity of personalized medicine approach

3.6.2.Restraint

3.6.2.1.Unclear reimbursement policies
3.6.2.2.Stringent regulatory policies

3.6.3.Opportunities

3.6.3.1.Potential opportunities for outsourcing
3.6.3.2.Convergence of new technologies

3.6.4.Impact Analysis

3.7.COVID-19 Impact Analysis for In Vitro Diagnostics Market

CHAPTER 4:IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

4.1.Overview

4.1.1.Market size and forecast

4.2.Reagents

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Instruments

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Software & Services

4.4.1.Market size and forecast, by region
4.4.2.Market analysis, by country

CHAPTER 5:IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE

5.1.Overview

5.1.1.Market size and forecast

5.2.Immunodiagnostics

5.2.1.Market size and forecast, by type

5.2.1.1.Enzyme-linked immunosorbent assay (ELISA)

5.2.1.1.1.Market size and forecast, by type
5.2.1.1.2.Chemiluminescence Immunoassay (CLIA)

5.2.1.1.2.1.Market size and forecast

5.2.1.1.3.Fluoresence immunoassay (FIA)

5.2.1.1.3.1.Market size and forecast

5.2.1.1.4.Colorimetric Immunoassay (CI)

5.2.1.1.4.1.Market size and forecast

5.2.1.2.Rapid Tests

5.2.1.2.1.Market size and forecast

5.2.1.3.Enzyme-linked immunospot (ELISPOT)

5.2.1.3.1.Market size and forecast

5.2.1.4.Radioimmunoassay (RIA)

5.2.1.4.1.Market size and forecast

5.2.1.5.Western blot

5.2.1.5.1.Market size and forecast

5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Hematology

5.3.1.Market size and forecast, by region
5.3.2.Market share analysis, by country

5.4.Molecular diagnostics

5.4.1.Market size and forecast, by type

5.4.1.1.Polymerize chain reaction (PCR)

5.4.1.1.1.Market size and forecast

5.4.1.2.Isothermal Nucleic acid amplification technology (INAAT)

5.4.1.2.1.Market size and forecast

5.4.1.3.Hybridization

5.4.1.3.1.Market size and forecast

5.4.1.4.DNA diagnostics

5.4.1.4.1.Market size and forecast

5.4.1.5.Microarray

5.4.1.5.1.Market size and forecast

5.4.1.6.Others

5.4.1.6.1.Market size and forecast

5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country

5.5.Tissue diagnostics

5.5.1.Market size and forecast, by region
5.5.2.Market share analysis, by country

5.6.Clinical chemistry

5.6.1.Market size and forecast, by type

5.6.1.1.Basic metabolic panel

5.6.1.1.1.Market size and forecast

5.6.1.2.Liver panel

5.6.1.2.1.Market size and forecast

5.6.1.3.Renal profile

5.6.1.3.1.Market size and forecast

5.6.1.4.Lipid profile

5.6.1.4.1.Market size and forecast

5.6.1.5.Thyroid function panel

5.6.1.5.1.Market size and forecast

5.6.1.6.Electrolyte panel

5.6.1.6.1.Market size and forecast

5.6.1.7.Specialty chemicals

5.6.1.7.1.Market size and forecast

5.6.2.Market size and forecast, by region
5.6.3.Market share analysis, by country

5.7.Others

5.7.1.Market size and forecast, by region
5.7.2.Market share analysis, by country

CHAPTER 6:IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Infectious Diseases

6.2.1.Market size and forecast, by region
6.2.2.Market share analysis, by country

6.3.Cancer

6.3.1.Market size and forecast, by region
6.3.2.Market share analysis, by country

6.4.Cardiac diseases

6.4.1.Market size and forecast, by region
6.4.2.Market share analysis, by country

6.5.Immune system disorders

6.5.1.Market size and forecast, by region
6.5.2.Market share analysis, by country

6.6.Nephrological diseases

6.6.1.Market size and forecast, by region
6.6.2.Market share analysis, by country

6.7.Gastrointestinal diseases

6.7.1.Market size and forecast, by region
6.7.2.Market share analysis, by country

6.8.Others

6.8.1.Market size and forecast, by region
6.8.2.Market share analysis, by country

CHAPTER 7:IN VITRO DIAGNOSTICS MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Standalone Laboratories

7.2.1.Market size and forecast, by region
7.2.2.Market share analysis, by country

7.3.Hospitals

7.3.1.Market size and forecast, by region
7.3.2.Market share analysis, by country

7.4.Academic and medical schools

7.4.1.Market size and forecast, by region
7.4.2.Market share analysis, by country

7.5.Point-of-care testing

7.5.1.Market size and forecast, by region
7.5.2.Market share analysis, by country

7.6.Others

7.6.1.Market size and forecast, by region
7.6.2.Market share analysis, by country

CHAPTER 8:IN VITRO DIAGNOSTICS MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country

8.2.2.1.U.S.

8.2.2.1.1.U.S. in vitro diagnostics market, by product & service
8.2.2.1.2.U.S. In vitro diagnostics market, by technique
8.2.2.1.3.U.S. In vitro diagnostics market, by application
8.2.2.1.4.U.S. In vitro diagnostics market, by end user

8.2.2.2.Canada

8.2.2.2.1.Canada iIn vitro diagnostics market, by product & service
8.2.2.2.2.Canada In vitro diagnostics market, by technique
8.2.2.2.3.Canada In vitro diagnostics market, by application
8.2.2.2.4.Canada In vitro diagnostics market, by end user

8.2.2.3.Mexico

8.2.2.3.1.Mexico In vitro diagnostics market, by product & service
8.2.2.3.2.Mexico In vitro diagnostics market, by technique
8.2.2.3.3.Mexico In vitro diagnostics market, by application
8.2.2.3.4.Mexico In vitro diagnostics market, by end user

8.2.3.Market size and forecast, by product & service
8.2.4.Market size and forecast, by technique
8.2.5.Market size and forecast, by application
8.2.6.Market size and forecast, by end user

8.3.Europe

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country

8.3.2.1.Germany

8.3.2.1.1.Germany In vitro diagnostics market, by product & service
8.3.2.1.2.Germany In vitro diagnostics market, by technique
8.3.2.1.3.Germany In vitro diagnostics market, by application
8.3.2.1.4.Germany In vitro diagnostics market, by end user

8.3.2.2.France

8.3.2.2.1.France In vitro diagnostics market, by product & service
8.3.2.2.2.France In vitro diagnostics market, by technique
8.3.2.2.3.France In vitro diagnostics market, by application
8.3.2.2.4.France In vitro diagnostics market, by end user

8.3.2.3.UK

8.3.2.3.1.UK In vitro diagnostics market, by product & service
8.3.2.3.2.UK In vitro diagnostics market, by technique
8.3.2.3.3.UK In vitro diagnostics market, by application
8.3.2.3.4.UK In vitro diagnostics market, by end user

8.3.2.4.Italy

8.3.2.4.1.Italy In vitro diagnostics market, by product & service
8.3.2.4.2.Italy In vitro diagnostics market, by technique
8.3.2.4.3.Italy In vitro diagnostics market, by application
8.3.2.4.4.Italy In vitro diagnostics market, by end user

8.3.2.5.Spain

8.3.2.5.1.Spain In vitro diagnostics market, by product & service
8.3.2.5.2.Spain In vitro diagnostics market, by technique
8.3.2.5.3.Spain In vitro diagnostics market, by application
8.3.2.5.4.Spain In vitro diagnostics market, by end user

8.3.2.6.Rest of Europe

8.3.2.6.1.Rest of Europe In vitro diagnostics market, by product & service
8.3.2.6.2.Rest of Europe In vitro diagnostics market, by technique
8.3.2.6.3.Rest of Europe In vitro diagnostics market, by application
8.3.2.6.4.Rest of Europe In vitro diagnostics market, by end user

8.3.3.Market size and forecast, by product & service
8.3.4.Market size and forecast, by technique
8.3.5.Market size and forecast, by application
8.3.6.Market size and forecast, by end user

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country

8.4.2.1.India

8.4.2.1.1.India In vitro diagnostics market, by product & service
8.4.2.1.2.India In vitro diagnostics market, by technique
8.4.2.1.3.India In vitro diagnostics market, by application
8.4.2.1.4.India In vitro diagnostics market, by end user

8.4.2.2.China

8.4.2.2.1.China In vitro diagnostics market, by product & service
8.4.2.2.2.China In vitro diagnostics market, by technique
8.4.2.2.3.China In vitro diagnostics market, by application
8.4.2.2.4.China In vitro diagnostics market, by end user

8.4.2.3.Japan

8.4.2.3.1.Japan In vitro diagnostics market, by product & service
8.4.2.3.2.Japan In vitro diagnostics market, by technique
8.4.2.3.3.Japan In vitro diagnostics market, by application
8.4.2.3.4.Japan In vitro diagnostics market, by end user

8.4.2.4.Australia

8.4.2.4.1.Australia In vitro diagnostics market, by product & service
8.4.2.4.2.Australia In vitro diagnostics market, by technique
8.4.2.4.3.Australia In vitro diagnostics market, by application
8.4.2.4.4.Australia In vitro diagnostics market, by end user

8.4.2.5.South Korea

8.4.2.5.1.South Korea In vitro diagnostics market, by product & service
8.4.2.5.2.South Korea In vitro diagnostics market, by technique
8.4.2.5.3.South Korea In vitro diagnostics market, by application
8.4.2.5.4.South Korea In vitro diagnostics market, by end user

8.4.2.6.Rest of Asia-Pacific

8.4.2.6.1.Rest of Asia-Pacific In vitro diagnostics market, by product & service
8.4.2.6.2.Rest of Asia-Pacific In vitro diagnostics market, by technique
8.4.2.6.3.Rest of Asia-Pacific In vitro diagnostics market, by application
8.4.2.6.4.Rest of Asia-Pacific In vitro diagnostics market, by end user

8.4.3.Market size and forecast, by product & service
8.4.4.Market size and forecast, by technique
8.4.5.Market size and forecast, by application
8.4.6.Market size and forecast, by end user

8.5.LAMEA

8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country

8.5.2.1.Brazil

8.5.2.1.1.Brazil In vitro diagnostics market, by product & service
8.5.2.1.2.Brazil In vitro diagnostics market, by technique
8.5.2.1.3.Brazil In vitro diagnostics market, by application
8.5.2.1.4.Brazil In vitro diagnostics market, by end user

8.5.2.2.Saudi Arabia

8.5.2.2.1.Saudi Arabia In vitro diagnostics market, by product & service
8.5.2.2.2.Saudi Arabia In vitro diagnostics market, by technique
8.5.2.2.3.Saudi Arabia In vitro diagnostics market, by application
8.5.2.2.4.Saudi Arabia In vitro diagnostics market, by end user

8.5.2.3.South Africa

8.5.2.3.1.South Africa In vitro diagnostics market, by product & service
8.5.2.3.2.South Africa In vitro diagnostics market, by technique
8.5.2.3.3.South Africa In vitro diagnostics market, by application
8.5.2.3.4.South Africa In vitro diagnostics market, by end user

8.5.2.4.Rest of LAMEA

8.5.2.4.1.Rest of LAMEA In vitro diagnostics market, by product & service
8.5.2.4.2.Rest of LAMEA In vitro diagnostics market, by technique
8.5.2.4.3.Rest of LAMEA In vitro diagnostics market, by application
8.5.2.4.4.Rest of LAMEA In vitro diagnostics market, by end user

8.5.3.Market size and forecast, by product & service
8.5.4.Market size and forecast, by technique
8.5.5.Market size and forecast, by application
8.5.6.Market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

9.1.ABBOTT LABORATORIES

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product and service portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.BECTON, DICKINSON AND COMPANY

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product and service portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.BIOMÉRIEUX SA

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product and service portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments

9.4.BIO-RAD LABORATORIES, INC.

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product and service portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.DANAHER CORPORATION (BECKMAN COULTER, INC.)

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product and service portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments

9.6.F. HOFFMANN-LA ROCHE AG.

9.6.1.Company snapshot
9.6.2.Operating business segments
9.6.3.Product and service portfolio
9.6.4.Business performance
9.6.5.Key strategic moves and developments

9.7.QIAGEN N.V.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product and service portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.SIEMENS AG (SIEMENS HEALTHINEERS)

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments

9.9.SYSMEX CORPORATION

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product and service portfolio
9.9.5.Business performance

9.10.THERMO FISHER SCIENTIFIC, INC.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product and service portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 02.IN VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.IN VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.IN VITRO DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 05.IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 06.IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.IN VITRO DIAGNOSTICS MARKET FOR ELISA, BY TYPE 2019–2027 ($MILLION)
TABLE 08.IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.IN VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 2019–2027 ($MILLION)
TABLE 10.MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 11.IN VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.IN VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 13.CLINICAL CHEMISTRY MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.IN VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2019–2027 ($MILLION)
TABLE 15.IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 16.IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 17.IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION,2019–2027 ($MILLION)
TABLE 18.IN VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 2019–2027 ($MILLION)
TABLE 19.IN VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 20.IN VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2019–2027 ($MILLION)
TABLE 21.IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 22.IN VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 23.IN VITRO DIAGNOSTICS MARKET FOR OTHER, BY REGION, 2019–2027 ($MILLION)
TABLE 24.IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 25.IN VITRO DIAGNOSTICS MARKET FOR STANDALONE LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 26.IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 27.IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOL, BY REGION,  2019–2027 ($MILLION)
TABLE 28.IN VITRO DIAGNOSTICS MARKET FOR POINT-OF-CARE TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 29.IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 30.IN VITRO DIAGNOSTICS MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 31.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 32.U.S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 33.U.S. IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 34.U.S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 35.U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 36.CANADA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 37.CANADA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 38.CANADA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 39.CANADA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 40.MEXICO IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 41.MEXICO IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 42.MEXICO IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 43.MEXICO IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 44.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 45.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 46.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 47.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 48.EUROPE IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 49.GERMANY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 50.GERMANY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 51.GERMANY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 52.GERMANY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 53.FRANCE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 54.FRANCE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 55.FRANCE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 56.FRANCE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 57.UK IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 58.UK IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 59.UK IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 60.UK IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 61.ITALY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 62.ITALY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 63.ITALY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 64.ITALY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 65.SPAIN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 66.SPAIN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 67.SPAIN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 68.SPAIN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 69.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 70.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 71.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 72.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 73.EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 74.EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 75.EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 76.EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 77.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 78.INDIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 79.INDIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 80.INDIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 81.INDIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 82.CHINA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 83.CHINA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 84.CHINA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 85.CHINA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 86.JAPAN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 87.JAPAN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 88.JAPAN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 89.JAPAN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 90.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 91.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 92.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 93.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 94.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 95.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 96.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 97.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 98.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 99.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 100.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 101.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 102.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 103.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 104.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 105.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 106.LAMEA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 107.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 108.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 109.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 110.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 111.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 112.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 113.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 114.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 115.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 116.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 117.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 118.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 119.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 120.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 121.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 122.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 123.LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 124.LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 125.LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 126.LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 127.ABBOTT: COMPANY SNAPSHOT
TABLE 128.ABBOTT: OPERATING SEGMENTS
TABLE 129.ABBOTT: PRODUCT AND SERVICE PORTFOLIO
TABLE 130.BD : COMPANY SNAPSHOT
TABLE 131.BD : OPERATING SEGMENTS
TABLE 132.BD: PRODUCT AND SERVICE PORTFOLIO
TABLE 133.BIOMÉRIEUX: COMPANY SNAPSHOT
TABLE 134.BIOMÉRIEUX: OPERATING SEGMENTS
TABLE 135.BIOMÉRIEUX: PRODUCT AND SERVICE PORTFOLIO
TABLE 136.BIO-RAD: COMPANY SNAPSHOT
TABLE 137.BIO-RAD: OPERATING SEGMENTS
TABLE 138.BIO-RAD: PRODUCT AND SERVICE PORTFOLIO
TABLE 139.DANAHER: COMPANY SNAPSHOT
TABLE 140.DANAHER: OPERATING SEGMENTS
TABLE 141.DANAHER: PRODUCT AND SERVICE PORTFOLIO
TABLE 142.ROCHE: COMPANY SNAPSHOT
TABLE 143.ROCHE: OPERATING SEGMENTS
TABLE 144.ROCHE: PRODUCT AND SERVICE PORTFOLIO
TABLE 145.QIAGEN: COMPANY SNAPSHOT
TABLE 146.QIAGEN: OPERATING SEGMENTS
TABLE 147.QIAGEN: PRODUCT AND SERVICE PORTFOLIO
TABLE 148.SIEMENS: COMPANY SNAPSHOT
TABLE 149.SIEMENS: OPERATING SEGMENTS
TABLE 150.SIEMENS: PRODUCT PORTFOLIO
TABLE 151.SYSMEX: COMPANY SNAPSHOT
TABLE 152.SYSMEX: OPERATING SEGMENTS
TABLE 153.SYSMEX: PRODUCT AND SERVICE PORTFOLIO
TABLE 154.THERMO FISHER: COMPANY SNAPSHOT
TABLE 155.THERMO FISHER: OPERATING SEGMENTS
TABLE 156.THERMO FISHER SCIENTIFIC: PRODUCT AND SERVICE PORTFOLIO

LIST OF FIGURES

FIGURE 01.IN-VITRO DIAGNOSTICS MARKET SEGMENTATION
FIGURE 02.TECHNIQUE MARKET SUB-SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.TOP WINNING STRATEGIES, 2017–2020
FIGURE 05.TOP WINNING STRATEGIES: NATURE AND TYPE, 2017–2020
FIGURE 06.TOP WINNING STRATEGIES: BY YEAR, 2017–2020
FIGURE 07.TOP PLAYER POSITIONING, 2019
FIGURE 08.BARGANING POWER OF BUYERS
FIGURE 09.BARGANING POWER OF SUPPLIERS
FIGURE 10.THREAT OF SUBSTITUTIONS
FIGURE 11.THREAT OF NEW ENTRANTS
FIGURE 12.MODERATE COMPETITIVE RIVALRY
FIGURE 13.IMPACT ANALYSIS, IN-VITRO DIAGNOSTICS MARKET
FIGURE 14.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY COUNTRY, 2019 & 2027
FIGURE 15.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2019 & 2027
FIGURE 16.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY,  2019 & 2027
FIGURE 17.IMMUNODIAGNOSTICS MARKET FOR ENZYME LINKED IMMUNOSORBENT ASSAY, 2019–2027 ($MILLION)
FIGURE 18.IMMUNODIAGNOSTICS MARKET FOR RAPID TESTS, 2019–2027 ($MILLION)
FIGURE 19.IMMUNODIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSPOT (ELISPOT), 2019–2027 ($MILLION)
FIGURE 20.IMMUNODIAGNOSTICS MARKET FOR RADIOIMMUNOASSAY (RIA), 2019–2027 ($MILLION)
FIGURE 21.IMMUNODIAGNOSTICS MARKET FOR WESTERN BLOT, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY,  2019 & 2027
FIGURE 23.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY, 2019 & 2027
FIGURE 24.MOLECULAR DIAGNOSTICS MARKET FOR POLYMERIZE CHAIN REACTION (PCR), 2019–2027 ($MILLION)
FIGURE 25.MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), 2019–2027 ($MILLION)
FIGURE 26.MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, 2019–2027 ($MILLION)
FIGURE 27.MOLECULAR DIAGNOSTICS MARKET FOR DNA DIAGNOSTICS, 2019–2027 ($MILLION)
FIGURE 28.MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, 2019–2027 ($MILLION)
FIGURE 29.MOLECULAR DIAGNOSTICS MARKET FOR OTHERS, 2019–2027 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019 & 2027
FIGURE 31.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY COUNTRY,  2019 & 2027
FIGURE 32.CLINICAL CHEMISTRY MARKET FOR BASIC METABOLIC PANEL, 2019–2027 ($MILLION)
FIGURE 33.CLINICAL CHEMISTRY MARKET FOR LIVER PANEL, 2019–2027 ($MILLION)
FIGURE 34.CLINICAL CHEMISTRY MARKET FOR RENAL PROFILE, 2019–2027 ($MILLION)
FIGURE 35.CLINICAL CHEMISTRY MARKET FOR LIPID PROFILE, 2019–2027 ($MILLION)
FIGURE 36.CLINICAL CHEMISTRY MARKET FOR THYROID FUNCTION PANEL, 2019–2027 ($MILLION)
FIGURE 37.CLINICAL CHEMISTRY MARKET FOR ELECTROLYTE PANEL, 2019–2027 ($MILLION)
FIGURE 38.CLINICAL CHEMISTRY MARKET FOR SPECIALTY CHEMICALS, 2019–2027 ($MILLION)
FIGURE 39.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY,  2019 & 2027
FIGURE 40.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR OTHERS IVD TECHNIQUES, BY COUNTRY,  2019 & 2027
FIGURE 41.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,  2019 & 2027
FIGURE 42.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 2019 & 2027
FIGURE 43.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY COUNTRY,  2019 & 2027
FIGURE 44.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY COUNTRY, 2019 & 2027
FIGURE 45.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2019 & 2027
FIGURE 46.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2019 & 2027
FIGURE 47.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR OTHER, BY COUNTRY, 2019 & 2027
FIGURE 48.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR STANDALONE LABORATORIES, BY COUNTRY, 2019 & 2027
FIGURE 49.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2019 & 2027
FIGURE 50.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY COUNTRY, 2019 & 2027
FIGURE 51.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY,  2019 & 2027
FIGURE 52.COMPARATIVE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027
FIGURE 53.U.S. IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 54.CANADA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 55.MEXICO IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 56.EUROPEAN GERIATRIC POPULATION (ABOVE 65 YEARS), 2017
FIGURE 57.GERMANY IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 58.FRANCE IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 59.UK. IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 60.ITALY IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 61.SPAIN IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 62.REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 63.INDIA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 64.CHINA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 65.JAPAN IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 66.AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 67.SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 68.REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 69.BRAZIL IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 70.SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 71.SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 72.REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, 2019–2027 ($MILLION)
FIGURE 73.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 74.ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2019 (%)
FIGURE 75.ABBOTT: NET SALES SHARE, BY REGION, 2019 (%)
FIGURE 76.BD: REVENUE, 2017–2019 ($MILLION)
FIGURE 77.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 78.BD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 79.BIOMÉRIEUX: NET SALES, 2016–2018 ($MILLION)
FIGURE 80.BIOMÉRIEUX: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 81.BIOMÉRIEUX: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 82.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 83.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 84.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 85.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 86.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 87.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 88.ROCHE: NET SALES, 2017–2019 ($MILLION)
FIGURE 89.ROCHE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 90.QIAGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 91.QIAGEN: REVENUE SHARE BY PRODUCT AND SERVICE, 2019 (%)
FIGURE 92.QIAGEN: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 93.NET SALES, 2017–2019 ($MILLION)
FIGURE 94.SIEMENS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 95.SIEMENS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 96.SYSMEX: REVENUE, 2017–2019 ($MILLION)
FIGURE 97.SYSMEX: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 98.SYSMEX: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 99.THERMO FISHER SCIENTIFIC: REVENUE, 2016–2018 ($MILLION)
FIGURE 100.THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 101.THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2018 (%)


 

 
 

In accordance to several interviews conducted, the utilization of IVD techniques is likely to witness a significant rise with increase in diseases diagnosis. The in vitro diagnostics market has piqued the interest of the healthcare industry, owing to its high accuracy and precise techniques coupled with wide range of application across various medical conditions, such as oncology, sexually transmitted diseases (STDs), chronic diseases, genetic testing, and infectious diseases. There have been remarkable advancements and some major developments in this market, such as devices with more throughput and accurate results. Owing to increase in chronic & infectious diseases, use of automated instruments, and rise in awareness regarding healthcare, North America is expected to emerge as a prominent leader in the global in vitro diagnostics market. 

According to the perspectives of CXOs of leading companies in the market, personalized medicine approach, cost-effective treatment, and technological advancements are some of the major factors that drive the global in vitro diagnostics market. However, lack of reimbursement rules and stringent regulatory policies hamper the market growth. Presently, standalone laboratories are the largest end user of IVD techniques followed by hospitals. 

As stated by CXOs, an increase in the number of chronic and infectious diseases raises the demand for IVD techniques, as it is the simplest technique for diagnosis of diseases. Therefore, use of IVD techniques, such as molecular diagnostics, point-of-care testing, and immunodiagnostics, in standalone laboratories and hospitals is expected to fuel the market growth in the future. In addition, the employment of IVD techniques is highest in North America, owing to increase in use of automated instruments, followed by Europe and Asia-Pacific. Further, use of minimally invasive techniques is also expected to boost the growth of the in vitro diagnostics market in Europe and Asia-Pacific.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total market value of In Vitro Diagnostics market is $67,110.72 million in 2019.

A. The forcast period for In Vitro Diagnostics market is 2020 to 2027

A. The market value of In Vitro Diagnostics market in 2019 is $65,432.95 million.

A. The base year is 2019 in In Vitro Diagnostics market

A. Top companies such as, Danaher Corporation (Beckman Coulter, Inc.), Thermo Fisher Scientific, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., and Siemens AG (Siemens Healthineers) held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Instruments segment is the most influencing segment as these devices are fully automated instruments and these simplify a task and provide more accurate and reliable results.

A. The major factor that fuels the growth of the global In Vitro Diagnostics market includes rise in prevalence of various chronic diseases such as diabetes, cancer and others which require the use of in vitro diagnostics

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as China with a CAGR of 6.7%. This is due to rise in number of patients suffering from chronic diseases and improving healthcare facilities in the region.

A. In vitro diagnostics is defined as medical devices which are used by laboratories to perform diagnostic tests inside a laboratory.

A. In vitro diagnostics (IVD) are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from human body to detect diseases, conditions, and infections.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
In Vitro Diagnostics Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts